Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2003
12/10/2003CA2389911A1 Broad spectruma antagonists and vaccines directed against pyrogenic exotoxins
12/09/2003US6660835 Lead substances and their use as therapeutics
12/09/2003US6660714 α-O-linked glycoconjugates, methods of preparation and uses thereof
12/09/2003US6660267 Prevention and treatment of sepsis
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/04/2003WO2003100432A2 Method for identifying immunoreactive peptides
12/04/2003WO2003100081A2 Biologically active maleamic acid derivatives with labile amide bonds
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100015A2 Polypeptide cleavage process
12/04/2003WO2003099868A2 Method for obtaining anti-idiotype antibodies
12/04/2003WO2003099857A1 Antagonistic peptides of prostaglandin e2 receptor subtype ep4
12/04/2003WO2003099853A2 Petide amidation process
12/04/2003WO2003099843A2 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
12/04/2003WO2003099842A2 Compositions and methods of use for a bombesin peptide
12/04/2003WO2003099780A2 Luminogenic protease substrates
12/04/2003WO2003068201A3 High affinity antibody having a tcr-like specificity and use in detection and treatment
12/04/2003WO2003064460A8 Two gonadotropin releasing hormones and a method to isolate the same
12/04/2003WO2003056297A3 Self-assembling polymers, and materials fabricated therefrom
12/04/2003WO2003050136A3 Peptide t stimulates ctl responses
12/04/2003WO2003026590A3 Biological control of nanoparticles
12/04/2003WO2003016561A3 Method for the production of cna
12/04/2003WO2003014145A3 Peptides that bind to atherosclerotic lesions
12/04/2003WO2003004601A3 New assays for preimplantation factor and preimplantation factor peptides
12/04/2003WO2002096936A3 Daptomycin and related analogs in crystalline form, their preparation and use
12/04/2003WO2002070555A3 Method of modulating the proliferation of medullary thyroid carcinoma cells
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003US20030226169 DNA sequences encoding antifungal proteins
12/04/2003US20030225251 Specificity exchangers that redirect antibodies to a pathogen
12/04/2003US20030225249 32-kDa protein derived from mycobacterium tuberculosis and related peptides
12/04/2003US20030224998 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/04/2003US20030224987 Binding to formyl peptide receptor or formyl peptide receptor-like 1
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224978 Compounds and methods for modulating apoptosis
12/04/2003US20030224494 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/04/2003US20030224480 Method of designing multifunctional base sequence
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030223981 Peptide inhibitors of protein kinase C gamma for pain management
12/04/2003US20030221931 Sliding device
12/04/2003CA2485737A1 Polypeptide cleavage process
12/04/2003CA2485485A1 Antagonistic peptides of prostaglandin e2 receptor subtype ep4
12/04/2003CA2485169A1 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
12/04/2003CA2480548A1 Compositions and methods of use for a bombesin peptide
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366076A2 Compounds and methods for modulating desmosomal cadherin-mediated functions
12/03/2003EP1366066A2 Cyclohexapeptide having antimicrobial activity
12/03/2003EP1366065A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
12/03/2003EP1366064A1 Tumour targeting prodrugs activated by metallo matrixproteinases
12/03/2003EP1366063A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancr
12/03/2003EP1365805A2 Novel targeted compositions for diagnostic and therapeutic use
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365791A2 Cyclosporins for the treatment of respiratory diseases
12/03/2003EP0952982B1 Novel hepatitis b inhibitors
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003EP0821004B1 Peptides and remedy for bone diseases containing the same as active ingredient
12/03/2003EP0772466B1 Compositions and methods for a bioartificial extracellular matrix
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129607C Method for producing peptides
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/02/2003US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
11/2003
11/27/2003WO2003097836A1 Method of accumulating arbitrary peptide in plant protein granules
11/27/2003WO2003097687A2 Neuroprotective polypeptides and methods of use
11/27/2003WO2003097671A1 Cytoplasmic transduction peptides and uses thereof
11/27/2003WO2003097667A1 Methods for measuring kinase activity and phosphatase activity
11/27/2003WO2003097105A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent (s)
11/27/2003WO2003097089A2 Attenuation of metapneumovirus
11/27/2003WO2003061590A3 Peptide constructs for treating disease
11/27/2003WO2003059942A9 Peptides and peptidomimetics having anti-proliferative activity and their use
11/27/2003WO2003048178A3 Nucleotide analogues and their use for nucleic acid sequencing
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003014144A3 Molecule
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006620A3 Linear and cyclic melanocortin receptor-specific peptides
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003US20030221222 Plant retroviral polynucleotides and methods for use thereof
11/27/2003US20030221201 Comprises chimeric transferrin-glucogon like polypeptide with reduced glycosylation, metal binding and receptor recognition for treatment and prevntion of multiple sclerosis, cancer and viral diseases
11/27/2003US20030220482 Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II
11/27/2003US20030220474 Conjugate of biodegradable aliphatic polyester with Tat49-57 peptide or peptide chain containing Tat49-57 peptide and nanoparticle manufactured using the same
11/27/2003US20030220265 Dihydroxypropyl cysteine peptide and agent containing this peptide
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220236 Acyl derivatives of the echinocandin class of cyclic peptide; parasiticide
11/27/2003US20030220235 Muteins of the CGRP 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers
11/27/2003US20030220234 A cyclosporine A derivative with isotopic or chemical substitution in the amino acid position selected from the group consisting of 1,3, and 9 or combination
11/27/2003US20030220233 Radiolabeled annexins
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003US20030219447 Biologically active peptides
11/27/2003US20030219383 Intramolecularly-quenched near infrared fluorescent probes
11/27/2003US20030219378 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003CA2486307A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/27/2003CA2483688A1 Methods for measuring kinase activity and phosphatase activity
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364011A2 Modified thrombopoietin with reduced immunogenicity
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 423